Dasman Diabetes Institute
Dasman Diabetes Institute
Kuwait City, Kuwait1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration? | Acid-Base Imbalance, Ketosis, Nutritional and Metabolic Diseases, acidosis disorder, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hypoglycemia, immune system disorder, metabolic disease, type 1 diabetes mellitus | Not yet recruiting | Phase 4 | 2025-08-29 | NCT06922656 |